We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIND icon
2701
Lindblad Expeditions
LIND
$2.22B
$370K ﹤0.01%
51,412
+1,340
+3% +$12.8K
SES icon
2702
SES AI
SES
$208M
$370K ﹤0.01%
163,007
+8,740
+6% +$21.2K
ONTF
2703
DELISTED
ON24
ONTF
$369K ﹤0.01%
58,356
-723
-1% -$5.33K
TSP
2704
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$369K ﹤0.01%
236,487
+6,331
+3% +$11.1K
HLVX
2705
DELISTED
HilleVax
HLVX
$369K ﹤0.01%
27,414
+838
+3% +$11.8K
DGICA icon
2706
Donegal Group Class A
DGICA
$714M
$368K ﹤0.01%
25,833
+454
+2% +$6.65K
ADV icon
2707
Advantage Solutions
ADV
$361M
$368K ﹤0.01%
5,182
-27
-0.5% -$1.79K
TARO
2708
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$368K ﹤0.01%
9,756
+419
+4% +$15.7K
FSV icon
2709
FirstService
FSV
$6.32B
$367K ﹤0.01%
2,524
+39
+2% +$5.96K
LPSN icon
2710
LivePerson
LPSN
$32.3M
$367K ﹤0.01%
6,295
-6
-0.1% -$395
BRT
2711
BRT Apartments
BRT
$271M
$366K ﹤0.01%
21,217
+9
+0% +$170
METC icon
2712
Ramaco Resources Class A
METC
$649M
$366K ﹤0.01%
34,454
-7,430
-18% -$62.3K
CMTL icon
2713
Comtech Telecommunications
CMTL
$51.8M
$366K ﹤0.01%
41,776
-6,515
-13% -$60.8K
CIVB icon
2714
Civista Bancshares
CIVB
$589M
$365K ﹤0.01%
23,570
+90
+0.4% +$1.56K
EWTX icon
2715
Edgewise Therapeutics
EWTX
$4.73B
$364K ﹤0.01%
63,610
+330
+0.5% +$2.24K
ME
2716
DELISTED
23andMe Holding Co
ME
$363K ﹤0.01%
18,581
+80
+0.4% +$2.24K
ENTA icon
2717
Enanta Pharmaceuticals
ENTA
$400M
$363K ﹤0.01%
32,480
-32,264
-50% -$520K
RMAX icon
2718
RE/MAX Holdings
RMAX
$242M
$362K ﹤0.01%
28,004
-31,064
-53% -$540K
RSI icon
2719
Rush Street Interactive
RSI
$2.88B
$361K ﹤0.01%
78,114
+1,466
+2% +$6.18K
FSBC icon
2720
Five Star Bancorp
FSBC
$1.13B
$360K ﹤0.01%
17,962
+91
+0.5% +$2.03K
MVST icon
2721
Microvast
MVST
$302M
$360K ﹤0.01%
190,636
-8,677
-4% -$18.6K
WOOF icon
2722
Petco
WOOF
$794M
$359K ﹤0.01%
87,887
-4,287
-5% -$28.2K
AURA icon
2723
Aura Biosciences
AURA
$826M
$359K ﹤0.01%
40,066
+389
+1% +$4.18K
UIS icon
2724
Unisys
UIS
$217M
$359K ﹤0.01%
104,002
-5,476
-5% -$23.2K
WSBF icon
2725
Waterstone Financial
WSBF
$375M
$358K ﹤0.01%
32,718
-469
-1% -$6.15K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.